NinePoint Medical Completes $34 Million Series B Financing to Expand Commercialization of its Breakthrough NvisionVLE™ Imaging

  NinePoint Medical Completes $34 Million Series B Financing to Expand
  Commercialization of its Breakthrough NvisionVLE™ Imaging System

Business Wire

CAMBRIDGE, Mass. -- March 20, 2014

NinePoint Medical, Inc., an emerging leader in the development of medical
devices for advanced optical imaging, today announced it has completed a $34
million Series B financing led by Corning Incorporated (NYSE: GLW), along with
founding investors Third Rock Ventures and Prospect Venture Partners. The
company also announced the addition of three new members to its board of
directors: Curt Weinstein from Corning, and independent directors Tom Miller
and Mark Stautberg.

Proceeds from the financing will support the ongoing commercial launch of the
NvisionVLE Imaging System in the U.S., as well as development of the company’s
expanded product offering.

“The NvisionVLE Imaging System is an exciting new imaging technology that is
enabling physicians to visualize esophageal abnormalities at and below the
mucosal surface, helping inform clinical decision-making,” said Charles S.
Carignan, M.D., president and CEO of NinePoint Medical. “With new hospitals
adopting the technology every month, and with the support of our investors and
strategic guidance of our board, we can continue to expand our sales force to
facilitate the adoption of NvisionVLE at more centers. Hospitals from New
England, to Florida, to California are already offering this advanced imaging
technology. We will continue to build out our operational capacity to meet the
increasing demand for our products, while also working on new features and
product offerings for the future.”

Originally developed at the Wellman Center for Photomedicine at The
Massachusetts General Hospital (MGH), NinePoint licensed the imaging
technology from MGH in 2010 as part of the largest intellectual property
agreement for medical device technology in the hospital’s history. The
NvisionVLE Imaging System enables physicians and pathologists to
endoscopically view, for the first time, real-time, high-resolution, cross
sectional images of organs and tissues up to 3mm deep at better than 10 micron
resolution.

“We are looking forward to being a part of NinePoint Medical’s success in
bringing this new imaging technology to market,” said Curt Weinstein, vice
president and general manager, Corning Advanced Optics and Specialty
Materials. “We are excited to bring Corning’s long history of excellence in
the development of optics to NinePoint to help develop industry leading
devices for OCT imaging that add to the clinical care of patients.”

Further expanding the expertise on the board of directors, Mr. Miller has
previously held senior positions with Siemens, Carl Zeiss, Analogic
Corporation and LightLab Imaging, and brings a wealth of international
operating experience to NinePoint’s board of directors. Mr. Stautberg joins
NinePoint’s board with more than 30 years of medical device sales and
marketing experience from Boston Scientific Corporation and Baxter Healthcare,
and currently serves as a director on the board of Baxano Surgical.

About The NvisionVLE^™ Imaging System

NinePoint Medical’s proprietary NvisionVLE Imaging System enables physicians
and pathologists to endoscopically view real-time, high-resolution, volumetric
images of organs and tissues up to 3mm deep at better than 10 micron
resolution. Utilizing an advanced form of Fourier-domain optical coherence
tomography (FD-OCT) also known as OFDI (optical frequency-domain imaging),
NvisionVLE provides treating physicians and pathologists with cross-sectional,
volumetric digital images of a patient’s organ – including below the surface
of the tissue, over very large areas. This imaging information can be used to
aid clinician decision-making relative to biopsy placement or treatment
planning. The NvisionVLE Imaging System is indicated for use as an imaging
tool in the evaluation of human tissue microstructure, including esophageal
tissue microstructure, by providing two-dimensional, cross-sectional,
real-time depth visualization. The safety and effectiveness of this device for
diagnostic analysis (i.e. differentiating normal versus specific
abnormalities) in any tissue microstructure or specific disease has not been
evaluated.

Developed at the Wellman Center for Photomedicine at Massachusetts General
Hospital (MGH), NinePoint licensed the technology in 2010 as part of the
largest intellectual property agreement for medical device technology in the
hospital’s history.

About NinePoint Medical, Inc.

NinePoint Medical is positioned to improve patient care through the
development of medical devices that enable high resolution in-vivo imaging.
The Company was founded on the ideal of convergence, of developing products
that could bring together access, diagnosis and treatment. Founded in 2009
with an initial Series A of $33 million, the Company licensed the fundamental
optical coherence tomography (OCT) technology from The Massachusetts General
Hospital (MGH) in 2010 and received its first 510(k) clearance from the U.S.
Food and Drug Administration in December 2011. NinePoint launched its lead
product, the NvisionVLE™ Imaging System, in the U.S. in May 2013. NinePoint is
headquartered in Cambridge, Mass. For more information, please visit
www.ninepointmedical.com.

About Corning Incorporated

Corning Incorporated (www.corning.com) is the world leader in specialty glass
and ceramics. Drawing on more than 160 years of materials science and process
engineering knowledge, Corning creates and makes keystone components that
enable high-technology systems for consumer electronics, mobile emissions
control, telecommunications and life sciences. Our products include glass
substrates for LCD televisions, computer monitors and laptops; ceramic
substrates and filters for mobile emission control systems; optical fiber,
cable, hardware & equipment for telecommunications networks; optical
biosensors for drug discovery; and other advanced optics and specialty glass
solutions for a number of industries including semiconductor, aerospace,
defense, astronomy, and metrology.

Contact:

NinePoint Medical, Inc. Communications Contact:
Pure Communications, Inc.
Katie Wilson, 910-509-3977
or
Corning Communications Contact:
Joe Dunning, 607-974-5006
dunningjm@corning.com
 
Press spacebar to pause and continue. Press esc to stop.